phosphatidylcholines has been researched along with Neutropenia in 19 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 4 (21.05) | 18.2507 |
| 2000's | 15 (78.95) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Sims-McCallum, RP | 1 |
| Estany, C; Gómez, L; Martí, JM; Martino, R; Sierra, J; Subirà, M | 1 |
| Brime, B; Frutos, G; Frutos, P; Molero, G | 1 |
| Auvrignon, A; Benoit, G; Demontoux, V; Fasola, S; Fratta, A; Le Guyader, N; Leverger, G; Pellegrino, B | 1 |
| Adler-Moore, J; Avanesian, V; Edwards, JE; Fu, Y; Ibrahim, AS; Schwartz, J; Spellberg, B | 1 |
| Blaich, A; Hopt, UT; Kaffarnik, M; Utzolino, S | 1 |
| Afif, C; Boktour, M; Hachem, RY; Hanna, HA; Jiang, Y; Kontoyiannis, DP; Raad, II; Torres, HA | 1 |
| Edwards, JE; Fu, Y; Gebremariam, T; Husseiny, MI; Ibrahim, AS; Spellberg, B; Stevens, DA | 1 |
| Barton, LL; Hutter, JJ; Patterson, TS; Shehab, ZM | 1 |
| Wingard, JR | 1 |
| Adedoyin, A; Anaissie, E; Bernardo, JF; Bolsack, LE; Boyle, A; Branch, RA; DeValeriola, D; DeWit, S; Horwith, G; Kelly, E; Klasterksy, J; Llanos-Cuentas, A; Lopez-Berestein, G; Sculier, JP; Swenson, CE | 1 |
| Kyi, AA; Myint, H; Winn, RM | 1 |
| Blair, D; Guharoy, R; Khan, U; Medicis, J; Ramirez, L; Rolland, WA | 1 |
| Lin, SJ; Schranz, J; Teutsch, SM | 1 |
| Andrès, E; Herbrecht, R; Letscher-Bru, V; Tiphine, M | 1 |
| Caillot, D; Kara-Slimane, F; Mannone, L | 1 |
| Frothingham, R | 1 |
| Cagnoni, PJ | 1 |
| Altés, A; Briones, J; Brunet, S; Martino, R; Sierra, J; Subirà, M; Sureda, A | 1 |
4 review(s) available for phosphatidylcholines and Neutropenia
| Article | Year |
|---|---|
Aspergillosis case-fatality rate: systematic review of the literature.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amphotericin B; Antifungal Agents; Aspergillosis; Bone Marrow Transplantation; Case-Control Studies; Central Nervous System Fungal Infections; Child; Child, Preschool; Clinical Trials as Topic; Cohort Studies; Drug Combinations; Female; Humans; Male; MEDLINE; Middle Aged; Neutropenia; Phosphatidylcholines; Phosphatidylglycerols; Prognosis | 2001 |
[New lipid formulations of amphotericin B. Review of the literature].
Topics: Amphotericin B; Antifungal Agents; Antiprotozoal Agents; Chemistry, Pharmaceutical; Drug Combinations; Fat Emulsions, Intravenous; Humans; Liposomes; Neutropenia; Patient Selection; Phosphatidylcholines; Phosphatidylglycerols; Treatment Outcome | 2001 |
[Invasive aspergillosis].
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Aspergillosis, Allergic Bronchopulmonary; Bronchoalveolar Lavage Fluid; Diagnosis, Differential; Drug Combinations; Humans; Immunosuppression Therapy; Itraconazole; Neuroaspergillosis; Neutropenia; Phosphatidylcholines; Phosphatidylglycerols; Postoperative Complications; Prognosis; Radiography, Thoracic; Risk Factors; Tomography, X-Ray Computed | 2001 |
Liposomal amphotericin B versus conventional amphotericin B in the empirical treatment of persistently febrile neutropenic patients.
Topics: Amphotericin B; Antifungal Agents; Drug Combinations; Humans; Liposomes; Neutropenia; Phosphatidylcholines; Phosphatidylglycerols | 2002 |
5 trial(s) available for phosphatidylcholines and Neutropenia
| Article | Year |
|---|---|
Low-dose amphotericin B lipid complex vs. conventional amphotericin B for empirical antifungal therapy of neutropenic fever in patients with hematologic malignancies--a randomized, controlled trial.
Topics: Adult; Amphotericin B; Antifungal Agents; Antineoplastic Combined Chemotherapy Protocols; Chemical and Drug Induced Liver Injury; Combined Modality Therapy; Drug Combinations; Female; Fever of Unknown Origin; Hematologic Neoplasms; Humans; Hypokalemia; Immunocompromised Host; Incidence; Kidney Diseases; Male; Middle Aged; Mycoses; Neutropenia; Peripheral Blood Stem Cell Transplantation; Phosphatidylcholines; Phosphatidylglycerols; Treatment Outcome | 2004 |
Novel antifungal agents as salvage therapy for invasive aspergillosis in patients with hematologic malignancies: posaconazole compared with high-dose lipid formulations of amphotericin B alone or in combination with caspofungin.
Topics: Adult; Amphotericin B; Antifungal Agents; Antineoplastic Combined Chemotherapy Protocols; Aspergillosis; Caspofungin; Combined Modality Therapy; Drug Combinations; Drug Therapy, Combination; Echinocandins; Female; Fungemia; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Itraconazole; Lipopeptides; Male; Middle Aged; Neutropenia; Phosphatidylcholines; Phosphatidylglycerols; Pyrimidines; Salvage Therapy; Treatment Outcome; Triazoles; Voriconazole | 2008 |
Efficacy of amphotericin B lipid complex injection (ABLC) in bone marrow transplant recipients with life-threatening systemic mycoses.
Topics: Adolescent; Adult; Amphotericin B; Antifungal Agents; Bone Marrow Transplantation; Child; Child, Preschool; Creatinine; Drug Combinations; Female; Humans; Male; Middle Aged; Mycoses; Neutropenia; Phosphatidylcholines; Phosphatidylglycerols | 1997 |
Pharmacokinetic profile of ABELCET (amphotericin B lipid complex injection): combined experience from phase I and phase II studies.
Topics: Amphotericin B; Antifungal Agents; Antineoplastic Agents; Area Under Curve; Chromatography, High Pressure Liquid; Drug Combinations; Drug Interactions; Half-Life; HIV Infections; Humans; Kidney Diseases; Leishmaniasis, Mucocutaneous; Mycoses; Neutropenia; Phosphatidylcholines; Phosphatidylglycerols; Reference Values | 1997 |
An open, non-comparative evaluation of the efficacy and safety of amphotericin B lipid complex as treatment of neutropenic patients with presumed or confirmed pulmonary fungal infections.
Topics: Adult; Aged; Amphotericin B; Antifungal Agents; Dose-Response Relationship, Drug; Drug Combinations; Drug Evaluation; Humans; Hypokalemia; Lung; Lung Diseases, Fungal; Middle Aged; Neutropenia; Phosphatidylcholines; Phosphatidylglycerols; Treatment Outcome | 1998 |
10 other study(ies) available for phosphatidylcholines and Neutropenia
| Article | Year |
|---|---|
Triple antifungal therapy for the treatment of invasive aspergillosis in a neutropenic pediatric patient.
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Caspofungin; Child; Drug Combinations; Drug Therapy, Combination; Echinocandins; Female; Humans; Leukemia, Myeloid, Acute; Lipopeptides; Neutropenia; Peptides; Peptides, Cyclic; Phosphatidylcholines; Phosphatidylglycerols; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole | 2003 |
Comparative therapeutic efficacy of a novel lyophilized amphotericin B lecithin-based oil-water microemulsion and deoxycholate-amphotericin B in immunocompetent and neutropenic mice infected with Candida albicans.
Topics: Amphotericin B; Animals; Candidiasis; Chemistry, Pharmaceutical; Deoxycholic Acid; Emulsions; Freeze Drying; Immunocompetence; Male; Mice; Neutropenia; Phosphatidylcholines | 2004 |
[Role of Abelcet in children with febrile neutropenia].
Topics: Amphotericin B; Antifungal Agents; Child; Creatinine; Drug Combinations; Fever; Hematologic Neoplasms; Humans; Kidney Function Tests; Neutropenia; Phosphatidylcholines; Phosphatidylglycerols; Retrospective Studies | 2004 |
Comparison of antifungal treatments for murine fusariosis.
Topics: Amphotericin B; Animals; Antifungal Agents; Brain; Caspofungin; Drug Combinations; Echinocandins; Fusarium; Kidney; Lipopeptides; Male; Mice; Mice, Inbred BALB C; Mycoses; Neutropenia; Peptides, Cyclic; Phosphatidylcholines; Phosphatidylglycerols | 2006 |
Successful multimodal therapy of invasive pulmonary and central nervous system aspergillosis in a neutropenic surgical patient: case report and review of the literature.
Topics: Amphotericin B; Antifungal Agents; Aspergillosis, Allergic Bronchopulmonary; Drug Combinations; Drug Therapy, Combination; Female; Humans; Middle Aged; Neuroaspergillosis; Neutropenia; Phosphatidylcholines; Phosphatidylglycerols; Pyrimidines; Triazoles; Voriconazole | 2008 |
Comparison of lipid amphotericin B preparations in treating murine zygomycosis.
Topics: Amphotericin B; Animals; Antifungal Agents; Diabetic Ketoacidosis; Disease Models, Animal; Drug Combinations; Humans; Liposomes; Male; Mice; Mice, Inbred BALB C; Neutropenia; Phosphatidylcholines; Phosphatidylglycerols; Rhizopus; Treatment Outcome; Zygomycosis | 2008 |
Amphotericin B lipid complex treatment of a leukemic child with disseminated Fusarium solani infection.
Topics: Amphotericin B; Antifungal Agents; Child, Preschool; Dermatomycoses; Drug Combinations; Drug Resistance, Microbial; Female; Fusarium; Humans; Immunocompromised Host; Mycoses; Neutropenia; Paranasal Sinus Diseases; Phosphatidylcholines; Phosphatidylglycerols; Precursor Cell Lymphoblastic Leukemia-Lymphoma | 1996 |
Respiratory distress secondary to both amphotericin B deoxycholate and lipid complex formulation.
Topics: Adenocarcinoma; Aged; Amphotericin B; Anemia; Antifungal Agents; Colonic Neoplasms; Drug Combinations; Female; Fever; Humans; Infusions, Intravenous; Leukemia, Myeloid, Acute; Neutropenia; Phosphatidylcholines; Phosphatidylglycerols; Respiratory Distress Syndrome | 2000 |
Mortality rates in comparative trials of formulations of amphotericin B.
Topics: Amphotericin B; Antifungal Agents; Drug Combinations; Fever; Humans; Liposomes; Mycoses; Neutropenia; Phosphatidylcholines; Phosphatidylglycerols; Randomized Controlled Trials as Topic; Treatment Outcome | 2001 |
Safety and efficacy of low-dose amphotericin B lipid complex for empirical antifungal therapy of neutropenic fever in patients with hematologic malignancies.
Topics: Adolescent; Adult; Aged; Amphotericin B; Antiviral Agents; Drug Combinations; Female; Fever; Hematologic Neoplasms; Humans; Hypokalemia; Kidney; Liver; Male; Middle Aged; Neutropenia; Phosphatidylcholines; Phosphatidylglycerols | 2001 |